Cerapedics
Cerapedics is an advanced orthobiologics company with the only biologic bone graft in spinal applications that incorporates a small peptide (P-15) as an attachment factor. i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) is only the second FDA PMA approved bone graft on the market, and it it’s novel mechanism of action (Attract, Attach, Activate) has shown to be statistically superior to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years.
It is the Mission of KASS to improve the quality of scientific knowledge, patient care, and clinical practice among professionals in the field of spinal disorders and promote social and cultural interaction between Korean American Spine Specialists.
Kass board of directors

Tom Cha, MD, MBA
President
Massachusetts General Hospital
Boston, MA

John Chi, MD
President-Elect
Brigham and Women's Hospital
Boston, MA

Don Park, MD
Treasurer
UCLA Department of Orthopaedic Surgery
Santa Monica, CA
